Cited by 48Infectious Encephalopathies and EncephalitisAutoimmune Neurological Disorders and TreatmentsHerpesvirus Infections and Treatments

Clinical Epidemiology, Risk Factors, and Outcomes of Encephalitis in Older Adults

Open access
Hansen, Michael A, Samannodi, Mohammed S, Castelblanco, Rodrigo Lopez, Hasbun, Rodrigo·2020·Clinical Infectious Diseases

Abstract

Background: Encephalitis is associated with significant morbidity and mortality, with unknown etiologies in the majority of patients. Large prognostic studies evaluating elderly patients are currently lacking. Methods: We performed a retrospective cohort of encephalitis cases in 19 hospitals from New Orleans, Louisiana, and Houston, Texas, between the years 2000 and 2017. Results: A total of 340 adult (aged ≥17 years) patients with confirmed encephalitis were enrolled, and 194 (57%) had unknown etiologies. A cerebrospinal fluid polymerase chain reaction (PCR) for herpes simplex virus (HSV) and varicella zoster virus was done in 237 (69%) and 82 (24%) patients, respectively. Furthermore, an arboviral serology was done in 169 (49%) patients and measurements of anti-N-methyl-D-aspartate receptor antibodies were taken in 49 (14%) patients. A total of 172 out of 323 patients (53%) had adverse clinical outcomes (ACOs) at discharge. Older individuals (>65 years of age) had a lower prevalence of human immunodeficiency virus, had a higher number of comorbidities, were less likely to receive adjuvant steroids, were more likely to have a positive arbovirus serology, were more likely to have a positive HSV PCR, were more likely to have abnormal computerized tomography findings, and were more likely to have to have an ACO (all P values < .05). Prognostic factors independently associated with an ACO were age ≥65, fever, Glasgow Coma Scale (GCS) score <13, and seizures (all P values ≤0.01). Conclusions: Encephalitis in adults remain with unknown etiologies and adverse clinical outcomes in the majority of patients. Independent prognostic factors include age ≥65 years, fever, GCS score <13, and seizures.

Integrity signals

Registry

Crossref · 10.1093/cid/ciz635

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies assessing prognosis using hard endpoints in the post-acyclovir era showed neurological impairment in 20-60% of VZV patients upon hospital discharge, 55% after one month, 51% after three months, and 71% after one year after the acute episode.

    “Studies assessing prognosis using hard endpoints in the post-acyclovir era showed neurological impairment in 20–60% of patients upon hospital discharge [62–64], 55% after one month, 51% after three months and 71% after one year [62, 65] after the acute episode.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hansen, M. A., Samannodi, M. S., Castelblanco, R. L., & Hasbun, R.
Affiliations
  • Baylor College of Medicine (US)
  • The University of Texas Health Science Center at Houston (US)
Corresponding author
Hasbun, Rodrigo
Venue
Clinical Infectious Diseases
Published
2019-07-10
Volume
70
Issue
11
Pages
2377-2385
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2961604107
Cited by
48
References
25
Citations by year
2026: 8 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 10 · 2021: 6 · 2020: 6
FWCI
4.24
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • SSRN Electronic Journal (acceptedVersion)
  • PubMed (publishedVersion)
Funders
A Starr Foundation
Topics
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
Keywords
encephalitis, older adults, prognostic factors, adverse clinical outcomes, unknown etiology, herpes simplex virus, varicella-zoster virus, NMDA receptor antibodies, comorbidities, seizures, fever, Glasgow Coma Scale
MeSH terms
Aged, Encephalitis, Humans, Louisiana, Retrospective Studies, Risk Factors, Texas, Encephalitis, Herpes Simplex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review